Arcadia Biosciences Inc. (NASDAQ: RKDA) open the trading on January 04, 2022, with great promise as it jumped 17.80% to $1.39. During the day, the stock rose to $1.65 and sunk to $1.23 before settling in for the price of $1.18 at the close. Taking a more long-term approach, RKDA posted a 52-week range of $0.97-$6.40.
The Basic Materials Sector giants’ yearly sales growth during the last 5-year period was 8.20%. Meanwhile, its Annual Earning per share during the time was 45.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 89.70%. This publicly-traded company’s shares outstanding now amounts to $22.18 million, simultaneously with a float of $20.37 million. The organization now has a market capitalization sitting at $31.68 million. At the time of writing, stock’s 50-day Moving Average stood at $1.4789, while the 200-day Moving Average is $2.2354.
Let’s gauge the efficiency of the firm, which has a total of 58 employees. It has generated 138,517 per worker during the last fiscal year. Meanwhile, its income per employee was -80,259. The stock had 8.00 Receivables turnover and 0.20 Total Asset turnover. For the Profitability, stocks gross margin was +35.29, operating margin was -267.92 and Pretax Margin of -76.55.
Arcadia Biosciences Inc. (RKDA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Agricultural Inputs industry. Arcadia Biosciences Inc.’s current insider ownership accounts for 8.16%, in contrast to 14.30% institutional ownership.
Arcadia Biosciences Inc. (RKDA) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2021 suggests? It has posted -$0.1 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.29) by $0.19. This company achieved a net margin of -57.94 while generating a return on equity of -26.28. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
Arcadia Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 89.70% and is forecasted to reach -1.06 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.96% through the next 5 years, which can be compared against the 45.10% growth it accomplished over the previous five years trading on the market.
Arcadia Biosciences Inc. (NASDAQ: RKDA) Trading Performance Indicators
Let’s observe the current performance indicators for Arcadia Biosciences Inc. (RKDA). It’s Quick Ratio in the last reported quarter now stands at 5.90. The Stock has managed to achieve an average true range (ATR) of 0.15. Alongside those numbers, its PE Ratio stands at $2.45, and its Beta score is -0.62. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.71.
In the same vein, RKDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.57, a figure that is expected to reach -0.28 in the next quarter, and analysts are predicting that it will be -1.06 at the market close of one year from today.
Technical Analysis of Arcadia Biosciences Inc. (RKDA)
[Arcadia Biosciences Inc., RKDA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 50.34% While, its Average True Range was 0.1638.
Raw Stochastic average of Arcadia Biosciences Inc. (RKDA) in the period of the previous 100 days is set at 24.62%, which indicates a major fall in contrast to 61.65% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 104.04% that was higher than 73.39% volatility it exhibited in the past 100-days period.